Genomics Revolution Meets Regulatory Evolution: Why Personalized Medicine Is Taking So Long
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA Commissioner Hamburg notes challenges of changing regulatory models to advance personalized medicine during AAAS/FDLI colloquium. But "we will establish a clear and illuminated pathway for product approval."